Related Experiment Video
Updated: Aug 18, 2026
Chromatin Immunoprecipitation Assay for Tissue-specific Genes using Early-stage Mouse Embryos
Published on: April 29, 2011
p38 mitogen-activated protein kinase (MAPK) first regulates filamentous actin at the 8-16-cell stage during
Andrew J M Paliga1, David R Natale, Andrew J Watson
1Department of Physiology and Pharmacology, University of Western Ontario, London, ON, Canada N6A 5C1.
Background Information:
The MAPK (mitogen-activated protein kinase) superfamily of proteins consists of four separate signalling cascades: the c-Jun N-terminal kinase or stress-activated protein kinases (JNK/SAPK); the ERKs (extracellular-signal-regulated kinases); the ERK5 or big MAPK1; and the p38 MAPK group of protein kinases, all of which are highly conserved. To date, our studies have focused on defining the role of the p38 MAPK pathway during preimplantation development. p38 MAPK regulates actin filament formation through the downstream kinases MAPKAPK2/3 (MAPK-activated protein kinase 2/3) or MAPKAPK5 [PRAK (p38 regulated/activated kinase)] and subsequently through HSP25/27 (heat-shock protein 25/27). We recently reported that 2-cell-stage murine embryos treated with cytokine-suppressive anti-inflammatory drugs (CSAIDtrade mark; SB203580 and SB220025) display a reversible blockade of development at the 8-16-cell stage, indicating that p38 (MAPK) activity is required to complete murine preimplantation development. In the present study, we have investigated the stage-specific action and role of p38 MAPK in regulating filamentous actin during murine preimplantation development.
Results:
Treatment of 8-cell-stage embryos with SB203580 and SB220025 (CSAIDtrade mark) resulted in a blockade of preimplantation development, loss of rhodamine phalloidin fluorescence, MK-p (phosphorylated MAPKAPK2/3), HSP-p (phosphorylated HSP25/27) and a redistribution of alpha-catenin immunofluorescence by 12 h of treatment. In contrast, treatment of 2- and 4-cell-stage embryos with CSAIDtrade mark drugs resulted in a loss of MK-p and HSP-p, but did not result in a loss of rhodamine phalloidin fluorescence. All these effects of p38 MAPK inhibition were reversed upon removal of the inhibitor, and development resumed in a delayed but normal manner to the blastocyst stage. Treatment of 8-cell embryos with PD098059 (ERK pathway inhibitor) did not affect development or fluorescence of MK-p, HSP-p or rhodamine phalloidin.
Conclusion:
Murine preimplantation development becomes dependent on p38 MAPK at the 8-16-cell stage, which corresponds to the stage when p38 MAPK first regulates filamentous actin during early development.
Insights
Murine preimplantation development requires p38 mitogen-activated protein kinase (MAPK) activity from the 8-16-cell stage onwards. This pathway regulates filamentous actin, crucial for early embryonic development.
Area of Science:
- Cell Biology
- Developmental Biology
- Molecular Biology
Background:
- The mitogen-activated protein kinase (MAPK) superfamily includes four key signaling cascades.
- p38 MAPK pathway is essential for regulating actin filament formation.
- Previous studies indicated p38 MAPK is required for murine preimplantation development completion.
Purpose of the Study:
- To investigate the stage-specific role of p38 MAPK in regulating filamentous actin.
- To define when p38 MAPK activity becomes essential during murine preimplantation development.
Main Methods:
- Treatment of murine embryos at different preimplantation stages (2-cell, 4-cell, 8-cell) with p38 MAPK inhibitors (SB203580, SB220025).
- Assessment of developmental progression, actin filament organization (rhodamine phalloidin), and phosphorylation of downstream targets (MAPKAPK2/3, HSP25/27).
- Inhibition of the ERK pathway using PD098059 as a control.
Main Results:
- p38 MAPK inhibition at the 8-cell stage blocked development, disrupted actin filaments, and altered protein phosphorylation.
- Inhibition at earlier stages (2-cell, 4-cell) affected phosphorylation but not actin organization.
- Effects were reversible upon inhibitor removal, with development resuming normally.
- ERK pathway inhibition did not impact development or actin regulation.
Conclusions:
- Murine preimplantation development becomes dependent on p38 MAPK at the 8-16-cell stage.
- p38 MAPK regulates filamentous actin during this critical developmental window.
- This study elucidates the precise timing and mechanism of p38 MAPK involvement in early embryonic development.
More Related Videos
09:32Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
08:13Spatiotemporal Subcellular Manipulation of the Microtubule Cytoskeleton in the Living Preimplantation Mouse Embryo using Photostatins
Published on: November 30, 2021
Related Concept Videos
02:38Mitogens and the Cell Cycle
01:13Actin Polymerization and Cell Motility
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate.
01:07MAPK Signaling Cascades
01:14Generation of Straight or Branched Actin Filaments
Arp2/3 Complex
Arp2/3 complex is a seven-subunit complex consisting of two proteins similar to actin- Arp2 and Arp3, and five other subunits that help keep Arp2 and Arp3 inactive. When required, the complex is...
01:17Intracellular Signaling Affects Focal Adhesions
Some...
01:39Mechanism of Filopodia Formation
Their main function is to guide migrating cells during normal tissue morphogenesis or cancer metastasis by recognizing and making initial contacts with the extracellular matrix. However, they can also act as stationary cell anchors or help to establish communication...